𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acute tumor lysis syndrome in poor-risk germ cell tumors: does it exist?

✍ Scribed by Joseph Kattan; Stéphane Culine; Tahereh Tavakoli-Razavi; Andrew Kramar; Jean-Pierre Droz


Publisher
Springer-Verlag
Year
1994
Tongue
English
Weight
360 KB
Volume
2
Category
Article
ISSN
0941-4355

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


VAB-5 combination chemotherapy in progno
✍ Davor Vugrin; Willet F. Whitmore; Robert B. Golbey 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 429 KB 👁 2 views

Forty-four patients with nonseminomatous germ cell tumors with "poor prognostic features" were entered on the VAB-5 regimen and 38 are evaluable. VAB-5 represents an intensified version of the VAB-4 protocol. Poor prognostic features were considered to be bulky metastases (>5 cm in diameter), palpab

Cisplatin-based (PVB+M) chemotherapy in
✍ Dr. Tapan Saikia; Upendra Hegde; Suresh Advani; Gopal Ramakrishnan; Jagdeesh Kul 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB

Twenty-seven patients with metastatic nonseminomatous germ cell tumors were treated with Cisplatin, vinblastine, bleomycin, and low-dose methotrexate (PVB + M) combinations. Patients were divided into good-risk and poor-risk groups. All seven patients (100%) with good-risk factors achieved complete

Serum tumor markers and patient allocati
✍ George J. Bosl; Nancy L. Geller; Dean Bajorin 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

The allocation of patients with advanced germ cell tumors (GCT) to different treatment programs based on clinical characteristics is standard in the design of clinical trials today. Studies have shown that substantial differences exist between entry criteria and that these differences could influenc